The first reaction of this enzyme is to catalyse its own glucosylation, normally at Tyr-194 of the protein if this group is free. When Tyr-194 is replaced by Thr or Phe, the enzyme's Mn2+-dependent self-glucosylation activity is lost but its intermolecular transglucosylation ability remains . It continues to glucosylate an existing glucosyl group until a length of about 5--13 residues has been formed. Further lengthening of the glycogen chain is then carried out by EC 2.4.1.11, glycogen (starch) synthase. The enzyme is not highly specific for the donor, using UDP-xylose in addition to UDP-glucose (although not glucosylating or xylosylating a xylosyl group so added). It can also use CDP-glucose and TDP-glucose, but not ADP-glucose or GDP-glucose. Similarly it is not highly specific for the acceptor, using water (i.e. hydrolysing UDP-glucose) among others. Various forms of the enzyme exist, and different forms predominate in different organs. Thus primate liver contains glycogenin-2, of molecular mass 66 kDa, whereas the more widespread form is glycogenin-1, with a molecular mass of 38 kDa.
The first reaction of this enzyme is to catalyse its own glucosylation, normally at Tyr-194 of the protein if this group is free. When Tyr-194 is replaced by Thr or Phe, the enzyme's Mn2+-dependent self-glucosylation activity is lost but its intermolecular transglucosylation ability remains [7]. It continues to glucosylate an existing glucosyl group until a length of about 5--13 residues has been formed. Further lengthening of the glycogen chain is then carried out by EC 2.4.1.11, glycogen (starch) synthase. The enzyme is not highly specific for the donor, using UDP-xylose in addition to UDP-glucose (although not glucosylating or xylosylating a xylosyl group so added). It can also use CDP-glucose and TDP-glucose, but not ADP-glucose or GDP-glucose. Similarly it is not highly specific for the acceptor, using water (i.e. hydrolysing UDP-glucose) among others. Various forms of the enzyme exist, and different forms predominate in different organs. Thus primate liver contains glycogenin-2, of molecular mass 66 kDa, whereas the more widespread form is glycogenin-1, with a molecular mass of 38 kDa.
glycogenin inactivation in mice results in an increased amount of glycogen and not glycogen depletion. Overproduction of glycogen secondary to glycogenin deficiency is associated with altered metabolism, affecting mainly oxidative muscle fibers and causing impaired endurance. Glycogenin KO mice show accumulation of glycogen instead of glycogen depletion, and no protein that functions as a substitute for glycogenin has been identified. The lack of glycogenin is associated with reduced endurance and a metabolic shift toward glycolytic metabolism in the otherwise fatigue-resistant oxidative muscle fibers. The results from the mouse glycogenin KO experiments support the concept that glycogenin is not mandatory for glycogen synthesis, although deficiency causes metabolic impairment with reduced endurance
glycogenin is a core protein in glycogen particles and functions as a glycosyl transferase with the ability to autoglucosylate. A primer protein is dispensable for glycogen synthesis. Glycogenin appears to have a role in the regulation of glycogen content